
doi: 10.5070/d33b67z1vb
pmid: 19061605
A 55-year-old woman with melasma develops biopsy-proved exogenous ochronosis in the setting of prolonged topical hydroquinone use. A limited number of similar reports exist in the US literature and are the basis for an FDA call to review hydroquinone-based products. This case underscores the difficult therapeutic dilemma which this diagnosis presents to dermatologists.
Middle Aged, Melanosis, Hydroquinones, Diagnosis, Differential, Humans, Female, Dermatologic Agents, Ochronosis, Facial Dermatoses
Middle Aged, Melanosis, Hydroquinones, Diagnosis, Differential, Humans, Female, Dermatologic Agents, Ochronosis, Facial Dermatoses
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
